References
- Hickman DM, Miller RA, Rombeau JL, Twomey PL, Frey CF. Serum albumin and body weight as predictors of postoperative course in colorectal cancer. JPEN J Parenter Enteral Nutr. 1980;4(3):314–316. doi:https://doi.org/10.1177/014860718000400315
- van Wissen J, van Stijn MFM, Doodeman HJ, Houdijk APJ. Mini nutritional assessment and mortality after hip fracture surgery in the elderly. J Nutr Health Aging. 2016;20(9):964–968. doi:https://doi.org/10.1007/s12603-015-0630-9
- Voisinet M, Venkatasamy A, Alratrout H, Delhorme J-B, Brigand C, Rohr S, Gaiddon C, Romain B. How to prevent sarcopenia occurrence during neoadjuvant chemotherapy for oesogastric adenocarcinoma?Nutr Cancer. 2021;73(5):802–808. doi:https://doi.org/10.1080/01635581.2020.1770813
- Detsky AS, Baker JP, O’Rourke K, Johnston N, Whitwell J, Mendelson RA, Jeejeebhoy KN. Predicting nutrition-associated complications for patients undergoing gastrointestinal surgery. JPEN J Parenter Enteral Nutr. 1987;11(5):440–446. doi:https://doi.org/10.1177/0148607187011005440
- Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. doi:https://doi.org/10.1097/01.sla.0000133083.54934.ae
- Toiyama YUJI, Miki C, Inoue Y, Tanaka KOJI, Mohri Y, Kusunoki M. Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med. 2011;2(1):95–101. doi:https://doi.org/10.3892/etm.2010.175
- Ortiz-Reyes LA, Chang Y, Quraishi SA, Yu L, Kaafarani H, de Moya M, King DR, Fagenholz P, Velmahos G, Yeh DD, et al. Early enteral nutrition adequacy mitigates the neutrophil-lymphocyte ratio improving clinical outcomes in critically ill surgical patients. Nutr Clin Pract. 2019;34(1):148–155. doi:https://doi.org/10.1002/ncp.10177
- Pedersen JL, Pedersen PU, Damsgaard EM. Early nutritional follow-up after discharge prevents deterioration of ADL functions in malnourished, independent, geriatric patients who live alone—a randomized clinical trial. J Nutr Health Aging. 2016;20(8):845–853. doi:https://doi.org/10.1007/s12603-015-0629-2
- de Souza Costa MD, de Melo CYSV, de Amorim ACR, de Oliveira Cipriano Torres D, dos Santos ACO. Association between nutritional status, inflammatory condition, and prognostic indexes with postoperative complications and clinical outcome of patients with gastrointestinal neoplasia. Nutr Cancer. 2016;68(7):1108–1114. doi:https://doi.org/10.1080/01635581.2016.1206578
- Shiraishi A, Wakabayashi H, Yoshimura Y. Oral management in rehabilitation medicine: oral frailty, oral sarcopenia, and hospital-associated oral problems. J Nutr Health Aging. 2020;24(10):1094–1099. doi:https://doi.org/10.1007/s12603-020-1439-8
- Murakami M, Hirano H, Watanabe Y, Sakai K, Kim H, Katakura A. Relationship between chewing ability and sarcopenia in Japanese community-dwelling older adults. Geriatr Gerontol Int. 2015;15(8):1007–1012. doi:https://doi.org/10.1111/ggi.12399
- Nagata T, Nakase Y, Nakamura K, Sougawa A, Mochiduki S, Kitai S, Inaba S. Prognostic impact of a nutritional index including muscle volume in stage 4 colorectal cancer. In Vivo. 2016;30(6):885–891. doi:https://doi.org/10.21873/invivo.11009
- Mochiki E, Nakabayashi T, Kamimura H, Haga N, Asao T, Kuwano H. Gastrointestinal recovery and outcome after laparoscopy-assisted versus conventional open distal gastrectomy for early gastric cancer. World J Surg. 2002;26(9):1145–1149. doi:https://doi.org/10.1007/s00268-002-6286-8
- Milsom JW, Böhm B, Hammerhofer KA, Fazio V, Steiger E, Elson P. A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report. J Am Coll Surg. 1998;187(1):46–54. doi:https://doi.org/10.1016/S1072-7515(98)00132-X
- Grose D, Devereux G, Brown L, Jones R, Sharma D, Selby C, Morrison DS, Docherty K, McIntosh D, McElhinney P, et al. Simple and objective prediction of survival in patients with lung cancer: staging the host systemic inflammatory response. Lung Cancer Int. 2014;2014:731925: doi:https://doi.org/10.1155/2014/731925
- Pinato DJ, Shiner RJ, Seckl MJ, Stebbing J, Sharma R, Mauri FA. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Br J Cancer. 2014;110(8):1930–1935. doi:https://doi.org/10.1038/bjc.2014.145
- Demirelli B, Babacan NA, Ercelep Ö, Öztürk MA, Kaya S, Tanrıkulu E, Khalil S, Hasanov R, Alan Ö, Telli TA, et al. Modified Glasgow prognostic score, prognostic nutritional index and ECOG performance score predicts survival better than sarcopenia, cachexia and some inflammatory indices in metastatic gastric cancer. Nutr Cancer. 2021;73(2):230–238. doi:https://doi.org/10.1080/01635581.2020.1749290
- Woo HD, Kim K, Kim J. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis. Cancer Causes Control. 2015;26(11):1661–1170. doi:https://doi.org/10.1007/s10552-015-0663-8
- Chen H, Hu N, Chang P, Kang T, Han S, Lu Y, Li M. Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis. Panminerva Med. 2017;59(4):302–307. doi:https://doi.org/10.23736/S0031-0808.16.03236-5
- Nie D, Zhang L, Wang C, Guo Q, Mao X. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis. Arch Gynecol Obstet. 2020;301(6):1543–1551. doi:https://doi.org/10.1007/s00404-020-05581-8
- Qi F, Xu Y, Zheng Y, Li X, Gao Y. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis. Ann Transl Med. 2019;7(20):531. doi:https://doi.org/10.21037/atm.2019.09.160
- Jin J, Hu K, Zhou Y, Li W. Clinical utility of the modified glasgow prognostic score in lung cancer: a meta-analysis. PLoS One. 2017;12(9):e0184412. doi:https://doi.org/10.1371/journal.pone.0184412
- Hooper CE, Lyburn ID, Searle J, Darby M, Hall T, Hall D, Morley A, White P, Rahman NM, De Winton E, et al. The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication. Br J Cancer. 2015;112(7):1175–1182. doi:https://doi.org/10.1038/bjc.2015.62
- Morris-Stiff G, Gomez D, Prasad KR. C-reactive protein in liver cancer surgery. Eur J Surg Oncol. 2008;34(7):727–729. doi:https://doi.org/10.1016/j.ejso.2008.01.016
- Chamberlain JS. Cachexia in cancer-zeroing in on myosin. N Engl J Med. 2004;351(20):2124–2125. doi:https://doi.org/10.1056/NEJMcibr042889
- Rubin H. Cancer cachexia: its correlations and causes. Proc Natl Acad Sci U S A. 2003;100(9):5384–5389. doi:https://doi.org/10.1073/pnas.0931260100
- Straub RH, Cutolo M, Buttgereit F, Pongratz G. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med. 2010;267(6):543–560. doi:https://doi.org/10.1111/j.1365-2796.2010.02218.x
- Havel PJ. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood)). 2001;226(11):963–977. doi:https://doi.org/10.1177/153537020122601102
- Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004;50(9):1511–1525. doi:https://doi.org/10.1373/clinchem.2004.032482
- Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 2001;98(4):2005–2010. doi:https://doi.org/10.1073/pnas.98.4.2005
- Miller CL. Immunological assays as measurements of nutritional status: a review. J Parenter Enteral Nutr. 1978;2(4):554–566. doi:https://doi.org/10.1177/014860717800200406
- Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–899. doi:https://doi.org/10.1016/j.cell.2010.01.025
- Gregory AD, Houghton M. A: Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011;71(7):2411–2416. doi:https://doi.org/10.1158/0008-5472.CAN-10-2583
- Ding P-R, An X, Zhang R-X, Fang Y-J, Li L-R, Chen G, Wu X-J, Lu Z-H, Lin J-Z, Kong L-H, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis. 2010;25(12):1427–1433. doi:https://doi.org/10.1007/s00384-010-1052-0
- Neal CP, Mann CD, Garcea G, Briggs CD, Dennison AR, Berry DP. Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases. Arch Surg. 2011;146(4):471–478. doi:https://doi.org/10.1001/archsurg.2011.50
- Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91(3):181–184. doi:https://doi.org/10.1002/jso.20329
- Mallappa S, Sinha A, Gupta S, Chadwick SJD. Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis. 2013;15(3):323–328. doi:https://doi.org/10.1111/codi.12008
- Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JPA. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol. 2008;34(1):55–60. doi:https://doi.org/10.1016/j.ejso.2007.02.014
- Gomez D, Morris-Stiff G, Wyatt J, Toogood GJ, Lodge JPA, Prasad KR. Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol. 2008;98(5):371–376. doi:https://doi.org/10.1002/jso.21103
- Hung H-Y, Chen J-S, Yeh CY, Changchien C-R, Tang R, Hsieh P-S, Tasi W-S, You J-F, You Y-T, Fan C-W, et al. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis. 2011;26(8):1059–1065. doi:https://doi.org/10.1007/s00384-011-1192-x
- Gambardella C, Brusciano L, Del Genio G, Tolone S, Terracciano G, Gualtieri G, Lucido FS, Docimo L. Predictive parameters to identify incontinent patients amenable for rehabilitation treatment: the muscular synergies evaluation. Arq Gastroenterol. 2019;56(4):452–453. doi:https://doi.org/10.1590/S0004-2803.201900000-76